Immunic, Inc. | WebDisclosure

Basculer en Français

8201	Companies
109005	Keywords
51275	Articles
60079	Press releases

Home
Companies
Immunic, Inc.

BRIEF

published on 03/07/2024 at 12:35, 7 months 27 days ago

Immunic, Inc. annonce sa participation aux prochaines conférences scientifiques et investisseurs

Immunic, Inc. Maladies Auto-immunes Conférence Des Investisseurs Conférence Scientifique Inflammatoire Chronique
BRIEF

published on 03/07/2024 at 12:35, 7 months 27 days ago

Immunic, Inc. Announces Participation in Upcoming Investor and Scientific Conferences

Investor Conference Immunic, Inc. Autoimmune Diseases Scientific Conference Chronic Inflammatory
PRESS RELEASE

published on 03/07/2024 at 12:30, 7 months 27 days ago

Immunic to Participate in Investor and Scientific Conferences in March
Immunic, Inc. (Nasdaq: IMUX) announces participation in investor and scientific conferences in March, presenting abstracts and posters showcasing their clinical pipeline of therapies for inflammatory and autoimmune diseases

Investor Conference Biotechnology Clinical Pipeline Scientific Conference Immunic Inc
PRESS RELEASE

published on 02/29/2024 at 12:30, 8 months 3 days ago

Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024
Immunic presents data from phase 2 CALLIPER and CALVID-1 trials of vidofludimus calcium at ACTRIMS Forum 2024. Positive results on serum neurofilament levels and EBV reactivation

Multiple Sclerosis Immunic Vidofludimus Calcium Phase 2 Trials ACTRIMS Forum
BRIEF

published on 02/29/2024 at 12:30, 8 months 3 days ago

Immunic, Inc. Presents Phase 2 Trial Data on Vidofludimus Calcium at ACTRIMS 2024 Forum

ACTRIMS Forum 2024 Multiple Sclerosis Immunic Vidofludimus Calcium Phase 2 Trials
BRIEF

published on 02/29/2024 at 12:30, 8 months 3 days ago

Immunic, Inc. présente les données des essais de Phase 2 sur le Vidofludimus Calcium au Forum ACTRIMS 2024

Sclérose En Plaques Immunic Vidofludimus Calcium Essais De Phase 2 Forum ACTRIMS 2024
BRIEF

published on 02/22/2024 at 12:30, 8 months 10 days ago

Immunic, Inc. annonce ses résultats financiers annuels 2023 et une mise à jour corporative

Immunic, Inc. Résultats Financiers Annuels Maladies Inflammatoires Sclérose En Plaques Thérapies Orales
BRIEF

published on 02/22/2024 at 12:30, 8 months 10 days ago

Immunic, Inc. announces its 2023 annual financial results and corporate update

Immunic, Inc. Annual Financial Results Inflammatory Diseases Multiple Sclerosis Oral Therapies
PRESS RELEASE

published on 02/22/2024 at 12:30, 8 months 10 days ago

Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update
Immunic, Inc. reports year end 2023 financial results and provides corporate update, including strengthened balance sheet and upcoming clinical milestones. Webcast scheduled for February 22, 2024

Financial Results Webcast Corporate Update Immunic Inc. Clinical Milestones
PRESS RELEASE

published on 02/15/2024 at 12:30, 8 months 17 days ago

Immunic, Inc. to Announce Financial Results for the Year Ended December 31, 2023, and Provide Corporate Update
Immunic, Inc. to announce financial results and corporate update for the year ended December 31, 2023. Webcast on February 22, 2024, at 8:00 am ET

Financial Results Webcast Corporate Update Immunic Inc. Clinical Pipeline

1 2 ... 4

Accesswire

Published on 11/03/2024 at 00:45, 12 hours 33 minutes ago

Holtway Global Hedge Expands into Europe, Providing Exclusive Pre-IPO and IPO Access to Companies Led by Visionary Founders like Elon Musk and Sam Altman
Published on 11/02/2024 at 19:15, 18 hours 3 minutes ago

Hank Payments Announces Closing of Financing and Settlements
Published on 11/02/2024 at 16:10, 21 hours 8 minutes ago

Savencia Cheese USA Announces Voluntary Recall of Select Soft Ripened Cheeses
Published on 11/02/2024 at 14:30, 22 hours 48 minutes ago

Spa Sciences Health Introduces Revolutionary Nasal Irrigation System at CVS
Published on 11/02/2024 at 00:48, 1 day 12 hours ago

OneSoft Solutions Inc. Announces the Completion of Its Acquisition by Irth Solutions LLC, a Blackstone Portfolio Company

View all ACCESSWIRE

EQS Group

Published on 11/01/2024 at 21:31, 1 day 15 hours ago

Original-Research: Telefonica Deutschland Holding AG (von First Berlin Equity Research GmbH): Buy
Published on 11/01/2024 at 18:18, 1 day 19 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/01/2024 at 17:47, 1 day 19 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/01/2024 at 17:10, 1 day 20 hours ago

EQS-Adhoc: fox e-mobility AG: provisional debt restructuring moratorium of Fox Automotive Switzerland AG
Published on 11/01/2024 at 16:00, 1 day 21 hours ago

Total Voting Rights

Les Echos

Published on 10/31/2024 at 20:26, 2 days 16 hours ago

I.CERAM - Résultat du 1er semestre 2024
Published on 10/31/2024 at 18:19, 2 days 18 hours ago

Déclaration hebdomadaire d'opérations effectuées du 28 au 31 octobre 2024
Published on 10/31/2024 at 18:19, 2 days 18 hours ago

Disclosure of transactions in own shares on October 28 to October 31, 2024
Published on 10/31/2024 at 18:00, 2 days 19 hours ago

GUILLEMOT CORPORATION : CHIFFRE D’AFFAIRES TROISIEME TRIMESTRE 2024 : +3%
Published on 10/31/2024 at 18:00, 2 days 19 hours ago

GUILLEMOT CORPORATION: THIRD QUARTER 2024 TURNOVER UP 3%

View all LES ECHOS COMFI WIRE